[Newsletter] Round-Up of COVID-19 Vaccine Updates: Week Commencing December 14, 2020

With the news on the novel coronavirus pandemic ever-changing, and the search for COVID-19 vaccines still continuing, it is difficult to stay on top of the goings-on of the vaccines in development. To help you stay on top of things, Nidhi Parekh of The Shared Microscope writes weekly updates on the vaccines alone.

Struggling to keep up with the goings-on of the COVID-19 vaccines?! We’ve got you covered! Check out our weekly COVID-19 Newsletter for the latest information on COVID-19 drugs and vaccines. #TSMUpdates #VaccineInfo #COVID19Updates

Tweet

---

For weekly updates on the COVID-19 vaccines, please do not forget to subscribe using the form below:

---

COVID-19 Top Vaccines

There are currently 19 COVID-19 vaccines in the final phase of clinical trials, some of which have received regulatory approval for use limited or full use in various countries. For more information on the regulatory process for vaccines (which is a labyrinth), check out this post here.

1. The Oxford/AstraZeneca Vaccine

What is The Oxford/AstraZeneca Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

In our vaccine newsletter from last week, we reported that news channels in the UK are expecting the Oxford vaccine to receive regulatory approval and be rolled out in the UK by New Year. 

According to the Independent, the Medicines and Healthcare Regulatory Agency (MHRA) is set to authorize the vaccines on December 28/29 after final data is provided to the regulatory body on Monday. 

---

2. The Moderna Vaccine

What is The Moderna Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, the US FDA granted the Moderna vaccine an Emergency Use Authorization for their mRNA-1273 COVID-19 vaccine in individuals that are 18 years and over. 

The European Commission has also exercised its option to purchase an additional 80 million doses of the mRNA-1273 vaccine. The European Commission’s confirmed order now stands at 160 million doses of the vaccine. 

---

3. Sinovac’s CoronaVac Vaccine

What is The CoronaVac Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no updates on this vaccine this week. For the latest update, check out our previous newsletter here. 

---

4. Cansino’s Ad5-nCoV

What is Cansino’s Ad5-nCoV Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Cansino has recruited over 20,000 volunteers for their Phase 3 clinical trials abroad. This is just above halfway through their planned 40,000 participant trial. Participants are being enrolled in Pakistan, Russia, Mexico, and Chile. 

---

5. Unnamed Inactive Vaccine – Wuhan

What is The Inactive Virus Vaccine From Wuhan And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Sinopharm is behind two of the Chinese coronavirus vaccines: the unnamed inactive virus vaccine from Wuhan and the BBIBP-CorV. Earlier last week, Peru halted the trials of Sinopharm’s COVID vaccine after a patient suffered neurological problems. This week, it was confirmed that the study of the Wuhan Unnamed Vaccine trials was halted and then resumed when it was determined that the neurological problems were not caused by the vaccine being studied.

---

6. Sinopharm’s BBIBP-CorV

What is Sinopharm’s BBIBP-CorV And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no updates on this vaccine this week. For our latest, check out our previous newsletter here. 

---

7. Pfizer and BioNTech’s BNT162b2

What is Pfizer and BioNTech’s BNT162 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

The UK was the first country in the world to approve a COVID-19 vaccine — Pfizer and BioNTech’s BNT162b2. A total of 138,000 people in the UK received the first dose of the vaccine in the first week of the rollout. 

Earlier today, the vaccine was approved by European regulators for use in EU countries. 

---

8. The Russian Sputnik V

What is theSputnik V And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

The Gamaleya Research Institute have announced earlier this week that their vaccine is 91.4% effective, after citing a new analysis of their Phase 3 clinical trial data. 

---

9. Novavax’s NVX-CoV2373

What is Novavax’s NVX-CoV2373 And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, Novavax announce its agreement with the government of New Zealand for 10.7 million doses of the NVX-CoV2373. 

The vaccine is still in Phase 3 clinical trials that are being conducted in the UK. 

---

10. Johnson & Johnson’s JNJ-78436735/Ad26.CoV2-S

What is Johnson & Johnson’s COVID-19 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Johnson and Johnson have announced this week that they have successfully enrolled ~45,000 participants for the late stage of their COVID-19 trials. As a reminder, the Johnson and Johnson vaccine differs from other competitors as it only requires a single shot of the vaccine. 

---

11. Murdoch Children’s Research Institute’s BCG Vaccine Trial

What is Murdoch Children’s Research Institute Doing?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Phase 3 clinical trial results for this vaccine are still to be declared. Since the trials started, we haven’t had any updates on the use of the BCG vaccine against COVID-19.

---

12. Bharat BioTech’s Covaxin

What is Bharat BioTech’s Covaxin And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Bharat Biotech released their Phase 1/2 trial results earlier this week. Results suggested that the vaccine did not cause any serious side effects, and also produced antibodies against COVID-19. The company expects results of the Phase 3 trials in early 2021. 

---

13. The Medicago-GSK Coronavirus-Like Particle (CoVLP)

What is Medicago’s Coronavirus-Like Particle (CoVLP)?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

14. Anhui Zhifei Longcom and Chinese Academy of Medical Sciences Vaccine Candidate

What is Anhui Zhifei Longform’s vaccine based on?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

15. The AnGes AG0302-COVID19

What is AnGes’ AG0302-COVID19 vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update on the vaccine, check out our post here. 

---

16. Institute of Medical Biology at the Chinese Academy of Medical Sciences’ Vaccine

What is the Institute of Medical Biology’s vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update on the vaccine, check out our post here. 

---

17. GSK-Clover Biopharmaceuticals’ COVID-19 Vaccine

What is Clover Biopharmaceuticals’ vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

On December 17, Clover Biopharmaceuticals announced that their vaccine has moved to Phase 2/3 of the clinical trials process. 

---

18. Vector Institute’s EpiVacCorona

What is the EpiVacCorona vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Russia’s Bektop Vector Institute began Phase 3 clinical trials in November having recruited nearly 30,000 participants for the trial. According to the NY Times, 1,438 volunteers have received the vaccine as of December 15. 

---

19. CureVac’s CVnCoV

What is CureVac’s CVnCoV vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, CureVac launched its Phase 3 clinical trial of their vaccine and has so far recruited 36,500 volunteers in Germany. 

---

For weekly updates on the COVID-19 vaccines delivered straight to your inbox, please do not forget to subscribe using the form below: